Maternal MitoQ Treatment Is Protective Against Programmed Alterations in CYP Activity Due to Antenatal Dexamethasone.
Saved in:
| Title: | Maternal MitoQ Treatment Is Protective Against Programmed Alterations in CYP Activity Due to Antenatal Dexamethasone. |
|---|---|
| Authors: | Bennett, Millicent G. A.1 (AUTHOR), Meakin, Ashley S.1,2 (AUTHOR), Botting-Lawford, Kimberley J.2,3 (AUTHOR), Niu, Youguo1,2 (AUTHOR), Ford, Sage G.2 (AUTHOR), Murphy, Michael P.3 (AUTHOR), Wiese, Michael D.1 (AUTHOR), Giussani, Dino A.2 (AUTHOR), Morrison, Janna L.1 (AUTHOR) janna.morrison@unisa.edu.au |
| Source: | Pharmaceutics. Mar2025, Vol. 17 Issue 3, p285. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
